Abbott Laboratories (XSWX:ABT) Total Tax Payable: CHF471 Mil (As of Mar. 2026)


XSWX:ABT Abbott Laboratories XSWX:ABT
80 GF Score
Price CHF77.50
GF Value CHF107.04
View Full Analysis

What is Abbott Laboratories Total Tax Payable?

Abbott Laboratories XSWX:ABT 80 Total Tax Payable is CHF471 Mil as of Mar. 2026. GuruFocus rates XSWX:ABT with a GF Score™ of 80/100 and a GF Value™ of CHF107.04.

Abbott Laboratories's Total Tax Payable for the quarter that ended in Mar. 2026 was CHF471 Mil.

Abbott Laboratories's quarterly Total Tax Payable increased from Sep. 2025 (CHF373 Mil) to Dec. 2025 (CHF453 Mil) and increased from Dec. 2025 (CHF453 Mil) to Mar. 2026 (CHF471 Mil).

Abbott Laboratories's annual Total Tax Payable increased from Dec. 2023 (CHF425 Mil) to Dec. 2024 (CHF530 Mil) but then declined from Dec. 2024 (CHF530 Mil) to Dec. 2025 (CHF453 Mil).

Abbott Laboratories Total Tax Payable Related Terms

Abbott Laboratories Total Tax Payable Historical Data

* Premium members only.

The historical data trend for Abbott Laboratories's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Abbott Laboratories Total Tax Payable Chart

Abbott Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Tax Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 281.83 319.54 425.48 529.61 453.44

Abbott Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Tax Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 428.55 317.15 373.37 453.44 470.81
XSWX:ABT
80GF Score
Abbott Laboratories XSWX:ABT
Total Tax Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Abbott Laboratories Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Frequently Asked Questions Learn more about Total Tax Payable →
What does a Total Tax Payable of CHF471 Mil mean?
Abbott Laboratories (XSWX:ABT) has a Total Tax Payable of CHF471 Mil as of Mar. 2026. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on Abbott Laboratories and its competitors.
Is Abbott Laboratories' Total Tax Payable too high?
Abbott Laboratories' current Total Tax Payable is CHF471 Mil. Overall, Abbott Laboratories has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories' Total Tax Payable compare to SYK and MDT?
Abbott Laboratories' Total Tax Payable of CHF471 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Tax Payable for a Medical Devices & Instruments company?
A good Total Tax Payable depends on the Medical Devices & Instruments industry context. However, Total Tax Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Tax Payable mean?
A high Total Tax Payable can signal that a stock is expensive relative to its fundamentals. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on Abbott Laboratories and its competitors. Abbott Laboratories's current Total Tax Payable is CHF471 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories stock overvalued right now?
Abbott Laboratories (XSWX:ABT) has a current Total Tax Payable of CHF471 Mil. The stock's GF Value™ is CHF107.04, compared to a current price of CHF77.50 — trading 27.6% below its estimated fair value. The current Total Tax Payable is CHF471 Mil. Abbott Laboratories' overall GF Score™ is 80/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Tax Payable calculated?
Total Tax Payable is calculated from a company's financial statements. For Abbott Laboratories (XSWX:ABT), the current Total Tax Payable is CHF471 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Abbott Laboratories (XSWX:ABT) Overvalued in 2026?

Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued. The current stock price of CHF77.50 is trading 27.6% below its estimated GF Value™ of CHF107.04.

Key valuation signals for XSWX:ABT:

  • Total Tax Payable: CHF471 Mil
  • GF Value™: CHF107.04 vs. price of CHF77.50 (27.6% below fair value)
  • GF Score™: 80/100

No single metric tells the full story. See the XSWX:ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Abbott Laboratories Business Description

Address 100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
80GF Score

Get the complete analysis for XSWX:ABT

Total Tax Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF77.50
Price
CHF107.04
GF Value